Acute-on-Chronic Hypercapnic Respiratory Failure

Acute decompensation of chronic CO2 retention — COPD, OHS, severe OSA, or neuromuscular disease; bicarbonate compensates chronically; pH falls acutely

Symptoms / Associated Sx

  • Dyspnea, tachypnea, confusion, somnolence (CO2 narcosis)

  • Paradoxical breathing (diaphragm fatigue — accessory muscles + abdominal paradox)

  • Morning headaches (CO2 retention overnight — OHS/OSA)

  • Peripheral edema (cor pulmonale — right heart failure from chronic hypoxia)

  • Polycythemia (chronic hypoxemia)

  • Asterixis (CO2 retention — same as hepatic encephalopathy)

Denies

  • Acute lung parenchymal disease (rules out primary hypoxemic failure as driver)

  • New medications causing respiratory depression (rules out opioid/sedative-induced hypoventilation if absent)

  • Focal neurologic deficits (rules out CNS cause of hypoventilation)

Social History (SHx)

COPD severity (FEV1 baseline), OHS (BMI, CPAP/BiPAP compliance), OSA diagnosis, neuromuscular disease (ALS, MG, post-polio, phrenic nerve injury), baseline ABG values, home oxygen use, prior intubation history, medication use (opioids, benzodiazepines, muscle relaxants).

Main Etiology

  • COPD exacerbation (most common) — acute air trapping worsens hypercapnia

  • Obesity hypoventilation syndrome (OHS) — reduced central drive + chest wall restriction

  • Severe OSA decompensation (especially without CPAP compliance)

  • Neuromuscular disease — ALS, GBS, MG, phrenic nerve palsy, post-polio syndrome

  • Central hypoventilation — opioid/sedative overdose, obesity-related hypoventilation, hypothyroidism

Most Common DDx

  • Acute hypoxemic respiratory failure without hypercapnia (PaO2 low but PCO2 low/normal; pneumonia, CHF, PE — different physiology and treatment)

  • Opioid-induced respiratory depression (PaCO2 elevated; miosis; reduced RR; responds to naloxone 0.4–2 mg IV — always exclude before attributing to underlying disease)

  • Metabolic alkalosis with compensatory hypoventilation (chronic diuretic use + hypokalemia → metabolic alkalosis → respiratory compensation elevates CO2; pH normal or high; correct electrolytes)

  • CNS lesion causing central hypoventilation (brainstem stroke, tumor, Ondine's curse — CT/MRI head; no pulmonary cause)

  • Hypothyroidism (severe myxedema — respiratory muscle weakness + reduced central drive; TSH very elevated; responds to thyroid hormone)

DATA

  • ABG — critical: pH (acute vs. chronic), PaCO2, PaO2, HCO3 (chronic retention: HCO3 elevated ~3.5 mEq/L per 10 mmHg rise in CO2; acute: HCO3 rises ~1 mEq/L per 10 mmHg — compare to expected)

  • SpO2 continuous; titrated O2 (COPD: target 88–92%)

  • CBC (polycythemia from chronic hypoxia)

  • BMP (electrolytes; creatinine; bicarbonate — confirms chronic compensation)

  • Thyroid function (hypothyroid hypoventilation)

  • CXR (hyperinflation, infiltrates, effusions)

  • Drug levels or urine toxicology (opioid/benzo-induced hypoventilation — always check)

  • Pulmonary function tests (if stable — FVC, FEV1, inspiratory capacity; deferred during acute)

  • Sleep study (OSA/OHS — if not previously done; plan outpatient)

  • NIF (neuromuscular disease — if suspected cause)

Home Meds

  • Opioids, benzodiazepines (hold immediately — primary contributor to acute decompensation)

  • Inhalers (COPD — continue and escalate)

  • Home CPAP/BiPAP (OHS/OSA — assess compliance; use home settings on admission)

  • Diuretics (cor pulmonale + edema — continue)

  • Thyroid hormone (hypothyroidism — assess compliance)

Plan

  • Treat the underlying cause first (COPD → bronchodilators + steroids; OHS → BiPAP + weight loss; opioid overdose → naloxone)

  • O2 delivery (COPD): target SpO2 88–92% — avoid hyperoxia worsening CO2 retention

  • BiPAP (primary intervention for pH <7.35 with elevated CO2):

    • COPD: IPAP 12–16, EPAP 4–6 cmH2O

    • OHS: IPAP 16–22, EPAP 8–10 cmH2O (higher settings needed); AVAPS mode preferred

    • Reassess ABG at 1–2h; serial ABG q2–4h while titrating

  • COPD exacerbation protocol: bronchodilators + steroids (prednisone 40 mg × 5 days) + antibiotics if purulent sputum (see COPD section)

  • Opioid reversal: Naloxone 0.4–2 mg IV; repeat q2–3 min; infusion if needed (titrate to RR >12/min; do NOT overshoot to precipitate withdrawal)

  • Correct electrolytes: hypokalemia and hypophosphatemia impair respiratory muscle function

  • Avoid sedating medications throughout admission

  • Serial ABG q4–8h (or q1–2h if on BiPAP/unstable)

  • Intubation indications: pH <7.20 after 1–2h BiPAP, CO2 narcosis (GCS declining), hemodynamic instability, respiratory arrest

  • Mechanical ventilation settings if intubated: assist-control; tidal volume 6–8 mL/kg IBW; PEEP 5–8 cmH2O; allow permissive hypercapnia (do NOT rapidly normalize CO2 — causes metabolic alkalosis and dysrhythmias)

  • Daily ABG; BMP; CBC; CXR; weaning trials early (spontaneous awakening trial + spontaneous breathing trial)

  • Pulmonology/critical care consult; sleep medicine for new OHS/OSA diagnosis

  • PT/OT — respiratory muscle training; early mobilization

  • Discharge: Home BiPAP/CPAP (new or adjusted prescription); pulmonary rehab referral; COPD optimization; weight loss program (OHS); sleep study if not done; eliminate respiratory depressants; pulmonology follow-up 2 weeks; repeat ABG in clinic to reassess baseline

Red Flags

  • pH <7.20 + altered mentation → CO2 narcosis → intubation; BiPAP contraindicated if unable to protect airway

  • Opioid or benzo on medication list + hypercapnia → always give naloxone/flumazenil empirically before attributing to underlying disease

  • NIF <-20 in neuromuscular disease → early elective intubation before crisis

  • Rapidly rising CO2 despite BiPAP + worsening pH → intubation urgently; do not delay

  • Cor pulmonale (right heart failure) in OHS/COPD + acute deterioration → ICU; diuresis + BiPAP; avoid vasopressors that increase RV afterload

Senior IM Resident Pearls

  • Chronic vs. acute hypercapnia: Chronic CO2 retainer has elevated HCO3 (compensated); pH near normal; acute decompensation = pH drops acutely with modest CO2 rise; target slow CO2 normalization (not rapid) to avoid overshooting into metabolic alkalosis

  • Permissive hypercapnia in mechanical ventilation — chronic CO2 retainers tolerate CO2 of 55–65 mmHg; rapid normalization causes acute metabolic alkalosis → dysrhythmias; set RR to achieve pH 7.30–7.35, not CO2 40 mmHg

  • OHS is underdiagnosed — consider in any obese patient with unexplained polycythemia, morning headaches, hypersomnolence, or elevated serum bicarbonate; diagnose by daytime ABG showing PaCO2 >45 with no other cause

  • Hypophosphatemia and hypokalemia cause respiratory muscle weakness and impair weaning from ventilator — always check and aggressively replete before extubation attempts

  • Common mistake: Rapidly correcting CO2 on the ventilator in a chronic CO2 retainer — set target based on patient's baseline, not normal values; overshoot causes post-hypercapnic metabolic alkalosis and paradoxical worsening of mental status

Acute-on-Chronic Hypercapnic Respiratory Failure — Senior Resident Rapid Recall

Think This When

  • COPD + pH <7.35 + PaCO₂ >45

  • Obesity + chronic CO₂ retention → OHS

  • OSA not using CPAP

  • Neuromuscular weakness + hypercapnia

Key Findings → Diagnosis

  • Somnolence + confusion + hypercapnia → CO₂ narcosis

  • Morning headaches + obesity + HCO₃ ↑ → OHS

  • Wheezing + smoking history → COPD

  • Asterixis + elevated CO₂ → Severe hypercapnia

  • Polycythemia + edema → Chronic hypoxemia/cor pulmonale

  • NIF <-25 → Neuromuscular respiratory failure

Key Labs

  • ABG: pH ↓ + PaCO₂ ↑

  • HCO₃ ↑ → Chronic CO₂ retainer

  • CBC: Polycythemia

  • BMP: Check K, Phos

  • Utox: Opioids/benzos

  • TSH: Hypothyroidism

First Questions

  • Is this COPD?

  • Is this OHS?

  • Did they get opioids/benzos?

  • Is there neuromuscular weakness?

Initial Management

  • Target SpO₂ 88–92%

  • BiPAP (first-line)

  • Repeat ABG in 1–2 hr

  • Hold opioids/benzos

  • Correct K and Phos

Medications

COPD

  • Duonebs

  • Prednisone 40 mg daily

  • Antibiotics if indicated

OHS

  • BiPAP (higher pressures)

Opioid-induced

  • Naloxone 0.4–2 mg IV

CHF component

  • Furosemide 40–80 mg IV

Reassess After 1–2 Hours

✅ pH improving
✅ PaCO₂ falling
✅ Mental status improving

→ Continue BiPAP

❌ pH worsening
❌ PaCO₂ rising
❌ CO₂ narcosis worsening

→ Intubate

Intubate If

  • pH <7.20

  • Cannot protect airway

  • Progressive AMS

  • Respiratory arrest

  • BiPAP failure

  • NIF <-20

Most Tested Pearls

  • Most common cause = COPD

  • Elevated HCO₃ = chronic CO₂ retention

  • Normal HCO₃ + hypercapnia = acute process

  • OHS = BMI >30 + PaCO₂ >45

  • Hypophosphatemia impairs weaning

  • Hyperoxia can worsen hypercapnia in COPD

Ventilator Pearl

  • Do NOT normalize CO₂ rapidly

  • Chronic retainers tolerate CO₂ 55–65

  • Goal: pH 7.30–7.35, not PaCO₂ 40

One-Line Memory Rules

  • COPD + hypercapnia → BiPAP

  • Obesity + HCO₃ ↑ + morning headaches → OHS

  • AMS + elevated CO₂ → CO₂ narcosis

  • Asterixis + hypercapnia = severe CO₂ retention

  • Target O₂ 88–92%

  • Elevated HCO₃ = chronic retainer

  • Opioids/benzos + hypercapnia → give naloxone, don't assume COPD

  • NIF <-25 worry, <-20 tube

  • pH improving = winning

  • pH worsening = intubate

  • Treat the cause, not just the CO₂

  • Never rapidly normalize CO₂ in chronic retainers